GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Related Keywords

Ankara ,Turkey ,Sudan ,Mark Newman ,Los Angeles ,David Dodd ,Pfizer ,Geovax Labs Inc ,Drug Administration ,Nasdaq ,Ongoing Phase ,Multi Antigen Vaccine ,Nucleocapsid Proteins ,Universal Booster ,Vax Labs ,Escalation Study ,Biologically Effective Dose ,Two Injections ,Healthy Adult ,Geovax Chief Scientific Officer ,Geovax President ,Zika Virus ,Coronavirus Pandemic ,Technology ,Health ,Business ,Newmediawire ,Cancer ,Clinical Trials ,